The potential for commonly infused drug solutions to support or inhibit microbial growth was explored in this study. Drugs examined were midazolam HCl, morphine sulphate, fentanyl citrate, pethidine HCl, bupivacaine HCl, atracurium besylate, vecuronium bromide, adrenaline, dopamine, dobutamine, noradrenaline, isoprenaline, glyceryl trinitrate, sodium nitroprusside and propofol. All drugs were studied in both diluted and undiluted forms. Of the 15 medications investigated, all except propofol were found to be bactericidal and to reduce fungal growth.
DumaR.J., WarnerJ.F., DaltonH.P.Septicemia from intravenous infusions.Engl J Med1971; 284: 257–260.
5.
MichaelsL., RubbnerB.Growth of bacteria in intravenous infusion fluids.Lancet1953; 1: 772–774.
6.
BennettS.N., McNeilM.M., BlandL.A.. Postoperative infections traced to contamination of an intravenous anaesthetic propofol.N Engl J Med1995; 333: 147–154.
7.
VeberB., GachotB., BedosJ.P., WolffM.Severe sepsis after intravenous injection of contaminated propofol.Anesthesiology1994; 80: 712–713.
8.
ArdunoM.J., BlandL.A., McAllisterS.K.. Microbial growth and endotoxin production in the intravenous anaesthetic propofol.Infect Control Hosp Epidemiol1991; 12: 535–539.
9.
WongC.L., WarrinorC.B., McCormackJ.P., ClarkeA.M.Reconstituted thiopentone retains its alkalinity without bacterial contamination for up to four weeks.Can J Anaesth1992; 39: 504–580.
10.
EstebanJ.M., DiazM.L., SorianoF., MarinE.Improved direct epifluorescent filter technique for rapid bioburden control in intraveous solution.J Parenter Sci Technol1992; 46: 146–149.
11.
BerryC.B., GillespieT., HoodJ., ScottN.B.Growth of microorganisms in solutions of intravenous anaesthetic agents.Anaesthesia1993; 48: 30–32.
12.
TesslerM., DascalA., CroseffaniS., MillerM., MendelsonJ.Growth curves of Staphylococcus aureus, Candida albicans and Moraxells osloensis in propofol and other media.Can J Anaesth1992; 39: 509–511.
13.
FarringtonM., McGuinnesJ., MatthewsI., ParkG.R.Do infusions of midazolam and propofol pose an infection risk to critically ill patients?Br J Anaesth1994; 72: 415–417.